nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGF3—cleft lip	0.00278	0.00278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGF3—cleft lip	0.00278	0.00278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGF3—cleft lip	0.00275	0.00275	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—FGFR1—cleft lip	0.00274	0.00274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—FGF10—cleft lip	0.00274	0.00274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGF3—cleft lip	0.00273	0.00273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGF3—cleft lip	0.00272	0.00272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—NOS3—cleft lip	0.00271	0.00271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGF9—cleft lip	0.00271	0.00271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGF9—cleft lip	0.00271	0.00271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGF9—cleft lip	0.00271	0.00271	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—MYC—cleft lip	0.0027	0.0027	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGF9—cleft lip	0.00269	0.00269	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—FGFR1—cleft lip	0.00268	0.00268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGF9—cleft lip	0.00266	0.00266	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—FGFR1—cleft lip	0.00266	0.00266	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00265	0.00265	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGF9—cleft lip	0.00265	0.00265	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—FGF10—cleft lip	0.00262	0.00262	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR1—cleft lip	0.0026	0.0026	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—FGFR3—cleft lip	0.00259	0.00259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—FGF10—cleft lip	0.00258	0.00258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—MYC—cleft lip	0.00258	0.00258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGF3—cleft lip	0.00257	0.00257	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—MTR—cleft lip	0.00253	0.00253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—FGFR3—cleft lip	0.00253	0.00253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGF7—cleft lip	0.00252	0.00252	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—MTR—cleft lip	0.00252	0.00252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—FGFR3—cleft lip	0.00251	0.00251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGF9—cleft lip	0.00251	0.00251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—FGF10—cleft lip	0.00247	0.00247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGF3—cleft lip	0.00246	0.00246	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—cleft lip	0.00245	0.00245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—FGF10—cleft lip	0.00245	0.00245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—NOS3—cleft lip	0.00245	0.00245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—FGF10—cleft lip	0.00244	0.00244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—FGF10—cleft lip	0.00243	0.00243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGF9—cleft lip	0.0024	0.0024	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGF10—cleft lip	0.00239	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGF8—cleft lip	0.00233	0.00233	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—MTHFR—cleft lip	0.0023	0.0023	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGF10—cleft lip	0.00229	0.00229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGF10—cleft lip	0.00229	0.00229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGF10—cleft lip	0.00229	0.00229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—FGF2—cleft lip	0.00227	0.00227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGF10—cleft lip	0.00227	0.00227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGF10—cleft lip	0.00225	0.00225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGF10—cleft lip	0.00224	0.00224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—FGF2—cleft lip	0.00222	0.00222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—FGFR2—cleft lip	0.0022	0.0022	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGF10—cleft lip	0.00212	0.00212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—FGFR2—cleft lip	0.00211	0.00211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—FGFR2—cleft lip	0.00207	0.00207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—FGFR1—cleft lip	0.00205	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGF10—cleft lip	0.00202	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—FGF2—cleft lip	0.002	0.002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—FGFR2—cleft lip	0.00198	0.00198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—FGFR2—cleft lip	0.00197	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—FGFR1—cleft lip	0.00196	0.00196	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—FGFR2—cleft lip	0.00196	0.00196	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—FGF2—cleft lip	0.00196	0.00196	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—FGFR2—cleft lip	0.00195	0.00195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—FGF2—cleft lip	0.00194	0.00194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—FGFR3—cleft lip	0.00194	0.00194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—FGFR1—cleft lip	0.00193	0.00193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR2—cleft lip	0.00192	0.00192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.0019	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—cleft lip	0.0019	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGF3—cleft lip	0.00189	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ARHGAP29—cleft lip	0.00188	0.00188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.00185	0.00185	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cleft lip	0.00185	0.00185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGF9—cleft lip	0.00185	0.00185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—FGFR1—cleft lip	0.00184	0.00184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Validated nuclear estrogen receptor alpha network—MYC—cleft lip	0.00184	0.00184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—FGFR1—cleft lip	0.00184	0.00184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGFR2—cleft lip	0.00183	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.00183	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGFR2—cleft lip	0.00183	0.00183	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—MTHFR—cleft lip	0.00183	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—FGFR1—cleft lip	0.00183	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—FGFR3—cleft lip	0.00183	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGFR2—cleft lip	0.00182	0.00182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—FGFR1—cleft lip	0.00182	0.00182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.0018	0.0018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGFR2—cleft lip	0.00179	0.00179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR1—cleft lip	0.00179	0.00179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—MYC—cleft lip	0.00178	0.00178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—FGFR3—cleft lip	0.00174	0.00174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—FGFR3—cleft lip	0.00173	0.00173	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—SLC19A1—cleft lip	0.00173	0.00173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—FGFR3—cleft lip	0.00173	0.00173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—FGFR3—cleft lip	0.00172	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.00171	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGFR1—cleft lip	0.00171	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGFR1—cleft lip	0.00171	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGFR2—cleft lip	0.0017	0.0017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGFR1—cleft lip	0.00169	0.00169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cleft lip	0.00169	0.00169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.00168	0.00168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGFR1—cleft lip	0.00167	0.00167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.00162	0.00162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.00162	0.00162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGFR3—cleft lip	0.00162	0.00162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGFR3—cleft lip	0.00162	0.00162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00161	0.00161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGFR3—cleft lip	0.0016	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.00159	0.00159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGFR1—cleft lip	0.00158	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGFR3—cleft lip	0.00158	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGF10—cleft lip	0.00156	0.00156	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—TYMS—cleft lip	0.00155	0.00155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.00151	0.00151	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—FGF2—cleft lip	0.0015	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGFR3—cleft lip	0.0015	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—MYC—cleft lip	0.00148	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—WNT9B—cleft lip	0.00147	0.00147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF7—cleft lip	0.00144	0.00144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—FGF2—cleft lip	0.00143	0.00143	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TCN2—cleft lip	0.00143	0.00143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.00143	0.00143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.00142	0.00142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—FGF2—cleft lip	0.00141	0.00141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF7—cleft lip	0.00138	0.00138	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—MTHFR—cleft lip	0.00136	0.00136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—FGF2—cleft lip	0.00135	0.00135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—FGF2—cleft lip	0.00134	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRF6—cleft lip	0.00134	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—FGF2—cleft lip	0.00133	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—FGF2—cleft lip	0.00133	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF8—cleft lip	0.00133	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.00132	0.00132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ABCA4—cleft lip	0.00131	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—cleft lip	0.00131	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF8—cleft lip	0.00127	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGFR2—cleft lip	0.00125	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.00125	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGF2—cleft lip	0.00125	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGF2—cleft lip	0.00125	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGF2—cleft lip	0.00124	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGF2—cleft lip	0.00123	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGF2—cleft lip	0.00122	0.00122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SLC19A1—cleft lip	0.0012	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.00117	0.00117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—WNT3—cleft lip	0.00117	0.00117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGFR1—cleft lip	0.00116	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGF2—cleft lip	0.00116	0.00116	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.00113	0.00113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.00111	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGFR3—cleft lip	0.0011	0.0011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF3—cleft lip	0.00108	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF9—cleft lip	0.00105	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—WNT9B—cleft lip	0.00103	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF9—cleft lip	0.00101	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TCN2—cleft lip	0.000994	0.000994	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTR—cleft lip	0.000993	0.000993	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOG—cleft lip	0.000988	0.000988	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000953	0.000953	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—NOS3—cleft lip	0.000946	0.000946	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000927	0.000927	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ABCA4—cleft lip	0.000918	0.000918	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SUMO1—cleft lip	0.000915	0.000915	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF10—cleft lip	0.000888	0.000888	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MYC—cleft lip	0.000878	0.000878	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—WNT9B—cleft lip	0.000872	0.000872	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF10—cleft lip	0.000853	0.000853	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGF2—cleft lip	0.000851	0.000851	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF7—cleft lip	0.000837	0.000837	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—WNT3—cleft lip	0.000819	0.000819	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ABCA4—cleft lip	0.000777	0.000777	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF7—cleft lip	0.000773	0.000773	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SPRY2—cleft lip	0.000773	0.000773	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF8—cleft lip	0.000773	0.000773	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000768	0.000768	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC19A1—cleft lip	0.00075	0.00075	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF8—cleft lip	0.000713	0.000713	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGFR2—cleft lip	0.000713	0.000713	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC19A1—cleft lip	0.000711	0.000711	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000696	0.000696	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—WNT3—cleft lip	0.000692	0.000692	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTR—cleft lip	0.000689	0.000689	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGFR2—cleft lip	0.000684	0.000684	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—cleft lip	0.000669	0.000669	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGFR1—cleft lip	0.000664	0.000664	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGFR1—cleft lip	0.000638	0.000638	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF3—cleft lip	0.000629	0.000629	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGFR3—cleft lip	0.000628	0.000628	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TCN2—cleft lip	0.000621	0.000621	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF9—cleft lip	0.000613	0.000613	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TYMS—cleft lip	0.000609	0.000609	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGFR3—cleft lip	0.000603	0.000603	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC19A1—cleft lip	0.000595	0.000595	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TCN2—cleft lip	0.000589	0.000589	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF3—cleft lip	0.000581	0.000581	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF9—cleft lip	0.000566	0.000566	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPRY2—cleft lip	0.000541	0.000541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF7—cleft lip	0.000541	0.000541	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—cleft lip	0.000532	0.000532	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF10—cleft lip	0.000517	0.000517	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF8—cleft lip	0.0005	0.0005	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TCN2—cleft lip	0.000493	0.000493	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF2—cleft lip	0.000485	0.000485	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF10—cleft lip	0.000478	0.000478	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF2—cleft lip	0.000466	0.000466	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SPRY2—cleft lip	0.000458	0.000458	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF7—cleft lip	0.000458	0.000458	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000455	0.000455	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTCH1—cleft lip	0.000449	0.000449	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTR—cleft lip	0.000431	0.000431	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF8—cleft lip	0.000423	0.000423	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR2—cleft lip	0.000415	0.000415	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTR—cleft lip	0.000408	0.000408	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF3—cleft lip	0.000407	0.000407	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF9—cleft lip	0.000396	0.000396	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR1—cleft lip	0.000387	0.000387	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR2—cleft lip	0.000383	0.000383	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—cleft lip	0.000371	0.000371	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—cleft lip	0.000369	0.000369	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR3—cleft lip	0.000366	0.000366	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR1—cleft lip	0.000357	0.000357	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF3—cleft lip	0.000344	0.000344	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTR—cleft lip	0.000342	0.000342	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR3—cleft lip	0.000338	0.000338	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF9—cleft lip	0.000335	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF10—cleft lip	0.000334	0.000334	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF10—cleft lip	0.000283	0.000283	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF2—cleft lip	0.000283	0.000283	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR2—cleft lip	0.000268	0.000268	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TYMS—cleft lip	0.000264	0.000264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF2—cleft lip	0.000261	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—cleft lip	0.000257	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR1—cleft lip	0.00025	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR3—cleft lip	0.000236	0.000236	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—cleft lip	0.000231	0.000231	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR2—cleft lip	0.000227	0.000227	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—cleft lip	0.000219	0.000219	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR1—cleft lip	0.000212	0.000212	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TYMS—cleft lip	0.000209	0.000209	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR3—cleft lip	0.0002	0.0002	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—cleft lip	0.000183	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF2—cleft lip	0.000183	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—cleft lip	0.00018	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—cleft lip	0.000171	0.000171	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—cleft lip	0.000161	0.000161	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF2—cleft lip	0.000155	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—cleft lip	0.000152	0.000152	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—cleft lip	0.000128	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—cleft lip	0.000119	0.000119	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—cleft lip	0.000101	0.000101	CbGpPWpGaD
